Abstract Background Reduced bone mineral density (BMD), osteoporosis and osteopenia, are prevalent comorbidities in IBD. Reduced BMD first line treatment is calcium and vitamin D supplementation. Mediterranean diet (MED) pattern has been associated with lower risk of reduced BMD in the general population. We aimed to assess the effectiveness of MED and vitamin D supplementation versus the standard of care on bone turn-over metabolites in patients with quiescent IBD diagnosed with reduced BMD. Methods Patients with IBD in clinical remission, age 20-50 years diagnosed with reduced BMD defined as DXA scan T score <-1were randomized for a 12-week, dietitian-led intervention to either MED (including calcium rich foods) or Calcium supplementation. Vitamin D supplementation was mandatory in both groups. Bone turn-over metabolites including bone resorption metabolite (CTX) and bone formation metabolite (P1NP) were used to assess bone dynamics within 12 weeks of treatment and vitamin D levels at baselined and after 12 weeks. Adherence to MED pattern was assed via validated MED score. Results Out of 72 patients approached, 38 (52.8%) consented to perform screening DXA and 17 (44.8%) were diagnosed with reduced BMD. Finally, 15 patients were recruited to the RCT- 7(46.6%) male 8 (53.4%) female, median age: 34 (IQR 29-40) years, median years since IBD diagnosis: 8 (IQR 7-16) years. Patients were randomized to MED (8) or Ca (7) groups. MED score increased in the MED group: median of 2.5 (IQR 2-3.75) points, but not the Ca group 0 (IQR 0-1) points (p=0.002). After 12 weeks of intervention Ca group demonstrated a reduction of 12.5% (IQR -126-12.2) in bone resorption metabolite, CTX. In the MED group an increase of bone resorption metabolite, CTX, by 18.2% (IQR -2.5-32) was observed. CTX dynamic significantly differed between groups (p=0.04) (fig 1). Bone formation metabolite, P1NP, decreased in both groups- in Ca group by 5.7 % (IQR -19.1- 9.5) and in MED group 10.2% (IQR -14-1.4). P1NP dynamic was comparable between groups. Vitamin D levels increased after 12 weeks in both Ca group and MED group (23.9 % vs 14.8%) the increase was comparable (p=0.536) Conclusion In this short-term intervention, we found that Ca supplementation significantly improved bone resorption in patients with IBD and reduced BMD, while MED (including calcium rich foods) alone was insufficient. Patients with IBD and reduced BMD should be encouraged to adhere to Ca supplementation for the long run to prevent long term metabolic bone complications.
Read full abstract